Washington Center for Bleeding Disorders

Seattle, Washington 98104

6 studies enrolling now · 8 studies all time

What they study most

Acquired Hemophilia A, Bleeding Disorder, Concomitant VWD and Hemophilia, Connective Tissue Disorder, Factor IX Deficiency, Factor VIII Deficiency, Hematologic Disorder, Hemophilia, Hemophilia A, Hemophilia B, Hemophilia B, Moderately Severe or Severe, Platelet Disorder

Studies at this site

• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A — Recruiting now
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders — Recruiting now
• Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD) — Recruiting now
• Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A — Recruiting now
• Von Willebrand Factor in Pregnancy (VIP) Study — Recruiting now
• Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) — Recruiting now
• BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B — Stopped early
• Emicizumab in Patients With Acquired Hemophilia A — Running, not enrolling